BioSyent
Listed on the TSX Venture Exchange under the trading symbol "RX", BioSyent is a specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical and other healthcare products. BioSyent supports the healthcare professionals that treat these patients by marketing its products through its community, specialty/hospital and international business units.
Last updated on
About BioSyent
Estimated Revenue
$10M-$50MEmployees
11-50Funding / Mkt. Cap
$7MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
32541Location
City
MississaugaState
OntarioCountry
CanadaBioSyent
Find your buyer within BioSyent